Krystal Biotech, Inc. (NASDAQ:KRYS) reported preliminary clinical findings from a pilot study of KB113, an investigational ...
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), announced results from a multicenter pilot study evaluating a standardized ...
CoHSTAR is pleased to announce that in 2023, we seek to fund up to two one-year pilot studies. Pilot studies may be designed to provide preliminary data that will support larger subsequent funding ...
A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (CKS). This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This ...
Addison Pain & Regenerative Medicine, 16633 Dallas Pkwy Suite 150, USA * Corresponding author: Maxwell Dordevic, Addison Pain & Regenerative Medicine, 16633 Dallas Pkwy Suite 150, USA Citation: East J ...
It will be a study of around 100 people, and enrollment is set to begin in the next few weeks.
Obtaining environmental data on contaminants of emerging concern is a priority area of interest for the U.S. Environmental Protection Agency, particularly the group of chemicals that includes ...